Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4590416
Max Phase: Preclinical
Molecular Formula: C58H100N2O6
Molecular Weight: 921.45
Molecule Type: Unknown
Associated Items:
ID: ALA4590416
Max Phase: Preclinical
Molecular Formula: C58H100N2O6
Molecular Weight: 921.45
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCCCCCCCCC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@]5(C(=O)NCCCCCCCCCCC(=O)N[C@H](C(=O)O)C(C)C)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C
Standard InChI: InChI=1S/C58H100N2O6/c1-11-12-13-14-15-16-20-23-26-29-49(62)66-47-33-34-55(8)45(54(47,6)7)32-35-57(10)46(55)31-30-43-44-41-53(4,5)36-38-58(44,39-37-56(43,57)9)52(65)59-40-27-24-21-18-17-19-22-25-28-48(61)60-50(42(2)3)51(63)64/h30,42,44-47,50H,11-29,31-41H2,1-10H3,(H,59,65)(H,60,61)(H,63,64)/t44-,45-,46+,47-,50-,55-,56+,57+,58-/m0/s1
Standard InChI Key: GBLPTIBPBDQMHB-XIDXUPOQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 921.45 | Molecular Weight (Monoisotopic): 920.7581 | AlogP: 14.47 | #Rotatable Bonds: 26 |
Polar Surface Area: 121.80 | Molecular Species: ACID | HBA: 5 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 4.21 | CX Basic pKa: 0.75 | CX LogP: 14.62 | CX LogD: 11.59 |
Aromatic Rings: 0 | Heavy Atoms: 66 | QED Weighted: 0.05 | Np Likeness Score: 1.49 |
1. Medina-O'Donnell M, Rivas F, Reyes-Zurita FJ, Cano-Muñoz M, Martinez A, Lupiañez JA, Parra A.. (2019) Oleanolic Acid Derivatives as Potential Inhibitors of HIV-1 Protease., 82 (10): [PMID:31617361] [10.1021/acs.jnatprod.9b00649] |
Source(1):